2[10]Maupoil V,Rochette L,Tabard A.et al. Evaluation of free radical formation during low-flow ischemia and reperfusion isolated rat heart[J]. Cardiovas Drugs Ther,1990,4(suppl 4):791-795
3[11]Guarniri C,Muscari C. Antioxy radical properties of trimetazidine[J]. Res Comnmm Chem Pathol Pharmocot,1989,64(2) :215-225
4[12]Williams FM,Tanda K,Kus M,et al. Trimetazidine inhibits neutrophil accumulation after myocardial ischemia and reperfusion in rabbits[J]. J Cardiovas Pharmacol, 1993,22(6) :828-833
5[13]Devynck MA,Joulin Y,Mazead M,et al. Acute membrane effects of trimetazidine in human platelets[J]. Eur J Pharmacol, 1993,245(2): 105-110
6[14]Layadic-Gossmanh D,Le Prigenf K,Feuvary D.et al. Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte[J]. Br J Phar maco1,1996,117(5),831-838
7[15]Sellier P,Audiouin P,Payen B,et al. Acute effects of trimetazidine eculuat ed by exercise testing[J]. Eur J Clin Pharmacol, 1987,33(2): 205-207
8[16]Passeron J. Effectiveness of trimetazidine in stable effort angina due to chornic coronary insufficiency. A double-blind veras placebo study[J].PresseMed,1986,15(3-5):1775-1778
9[17]Deuy JM,Fesler R,Berchmans T. A new semiautomated algorithm to quan tify holter-detected myocardial ischenia: preliminary experience in the trimetazidine European multicenter trial (TEMS) [ J ]. Cardiovasc Drugs Ther,1990,4(suppl 4):841-846
10[18]Detry JM. Clinical feature of anti-anginal drug in angiua pectoris[J]. Eur Heart J,1993,14(suppl G):18-24
